Semler Scientific, Inc. is a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Semler Scientific's mission is to develop, manufacture, and market innovative products that assist its customers in evaluating and treating chronic diseases. Semler Scientific commercially launched its first patented and FDA-cleared product in 2011, and received FDA 510(k) clearance for QuantaFlo®, the next generation version of this product, in 2015. QuantaFlo is a rapid point-of-care test that measures arterial blood flow in the extremities to aid in the diagnosis of cardiovascular diseases.
$85M sweet spot round size
2010
$85M
from investors over 1 rounds
Semler Scientific® raised $85M on February 23, 2025